☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+ Key Biosimilars Events of January 2022
February 3, 2022
Kodiak Sciences Reports Completion of Enrollment in P-III (GLEAM and GLIMMER) Trials of KSI-301 for Diabetic Macular Edema
February 3, 2022
Jazz Reports Completion of the US FDA’s sBLA for Approval of Rylaze (asparaginase erwinia chrysanthemi) to Treat ALL and LBL
February 3, 2022
Alvotech Entered into an Exclusive License Agreement with BiosanaPharma to Co-Develop AVT23, a Proposed Biosimilar to Xolair (omal...
February 3, 2022
PDS Biotech Provides Updates of PDS0101 + Keytruda (pembrolizumab) in P-II (VERSATILE-002) Trial for Advanced Head and Neck Cancer
February 3, 2022
Brickell Biotech Entered into a License Agreement with Carna to Develop and Commercialize BBI-10 for Autoimmune and Inflammatory D...
February 3, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions